Evaluation of Tumor Necrosis Factor-α, Lactate Dehydrogenase and Gamma -Glutamyl Transferase as Independent Predictors for Monitoring Progressive HCV-Chronic Liver Disease
El-Emshaty, H., Abdel Atty, M., Ibrahim, T., Elgazar, Y. (2017). Evaluation of Tumor Necrosis Factor-α, Lactate Dehydrogenase and Gamma -Glutamyl Transferase as Independent Predictors for Monitoring Progressive HCV-Chronic Liver Disease. EKB Journal Management System, 13(1), 136-146. doi: 10.21608/blj.2017.47606
Hoda Mohamed El-Emshaty; Mohy Eldin Abdelfatah Abdel Atty; Talat Abdallah Ibrahim; Yaser Mostafa Elgazar. "Evaluation of Tumor Necrosis Factor-α, Lactate Dehydrogenase and Gamma -Glutamyl Transferase as Independent Predictors for Monitoring Progressive HCV-Chronic Liver Disease". EKB Journal Management System, 13, 1, 2017, 136-146. doi: 10.21608/blj.2017.47606
El-Emshaty, H., Abdel Atty, M., Ibrahim, T., Elgazar, Y. (2017). 'Evaluation of Tumor Necrosis Factor-α, Lactate Dehydrogenase and Gamma -Glutamyl Transferase as Independent Predictors for Monitoring Progressive HCV-Chronic Liver Disease', EKB Journal Management System, 13(1), pp. 136-146. doi: 10.21608/blj.2017.47606
El-Emshaty, H., Abdel Atty, M., Ibrahim, T., Elgazar, Y. Evaluation of Tumor Necrosis Factor-α, Lactate Dehydrogenase and Gamma -Glutamyl Transferase as Independent Predictors for Monitoring Progressive HCV-Chronic Liver Disease. EKB Journal Management System, 2017; 13(1): 136-146. doi: 10.21608/blj.2017.47606

Evaluation of Tumor Necrosis Factor-α, Lactate Dehydrogenase and Gamma -Glutamyl Transferase as Independent Predictors for Monitoring Progressive HCV-Chronic Liver Disease

Biochemistry Letters
Article 12, Volume 13, Issue 1, 2017, Page 136-146  XML PDF (593.94 K)
Document Type: Original Article
DOI: 10.21608/blj.2017.47606
View on SCiNiTO View on SCiNiTO
Authors
Hoda Mohamed El-Emshaty1; Mohy Eldin Abdelfatah Abdel Atty2; Talat Abdallah Ibrahim3; Yaser Mostafa Elgazar3
1Gastro-Enterology Surgical Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt,
2Chemistry Department, Faculty of Science, Suez Canal University, Ismailia, Egypt,
3Gastro-Enterology Surgical Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt
Abstract
 




 Objective: Hepatocellular carcinoma (HC) ranks as the 5th most common malignant cancer and the 3rd most frequent cause of death worldwide. The majority of HCC patients are not amenable to curative therapy as they are detected at late stages. Therefore, our aim was to evaluate the clinical implications of TNF-α level and its correlation with the activities of GGT and LDH in monitoring the progression of HCV-chronic liver disease. 
Materials and methods: This study comprised forty eight patients suffering from HCV-chronic liver disease; 24(50%) cases with HCC, 14(29.2%) cases with LC and 10(20.8%) cases with CH. Twenty five healthy individuals (HI) served as control group. Sera of all individuals were examined for the activities of TNF-α, LDH, GGT, AFP and its correlation with other laboratory investigations. 
Results: Serum levels of TNF-α, LDH, AFP were elevated significantly in HCC patients compared to LC and CH but the difference between LC and CH was elevated significantly only (p<0.0001) in TNF-α. Significant association was recorded between LDH and TNF-α, GGT, AFP, ALT and ASTlevels. Linear regression for TNF-α, LDH and AFP showed significant prediction for progression of HCV-chronic liver disease. Conclusion: Serum level of LDH and TNF-αcould be used simultaneously with AFP for the evaluation of chronic inflammation leading to cancer development. 
Keywords
Tumor necrosis Factor-α (TNF-α); Lactate Dehydrogenase (LDH); Gamma Glutamyle Transferase (GGT); Alpha fetoprotein (AFP); HCV-chronic liver diseases
Statistics
Article View: 139
PDF Download: 210